Brief: Scopus Biopharma’s Subsidiary Reports Appointments Of John Rossi And Nagy Habib To Scientific Advisory Board
Sept 14 (Reuters) - Scopus Biopharma Inc SCPS.O :
* SCOPUS BIOPHARMA’S SUBSIDIARY — DUET THERAPEUTICS —
ANNOUNCES
APPOINTMENTS OF JOHN ROSSI, PH.D. AND NAGY HABIB, CH.M.,
F.R.C.S. TO THE SCIENTIFIC ADVISORY BOARD
Source text for Eikon: ID:nGNX69PzhM
Further company coverage: SCPS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scopus Biopharma
See all newsBrief: Scopus Biopharma - Nasdaq Hearings Panel Informed Company, By Letter Dated December 15, Of Its Determination To Delist Co's Common Stock From Nasdaq
Brief: Scopus Biopharma Completes Recapitalization To Enhance Shareholder Value
Brief: Scopus Biopharma Says Received Additional Non-Compliance Letter From Nasdaq
Brief: Scopus Biopharma Received Deficiency Letter From Nasdaq
Brief: Scopus BioPharma Inc- On April 4, Received Deficiency Notification Letter From Nasdaq Indicating Co Was Not In Compliance With Nasdaq Listing Rule